产品标题 产品货号 产品规格 厂家
Human aprataxin and PNKP like factor (APLF), full length from ORIGENE TECHNOLOGIESTP71031820 ugORIGENE TECHNOLOGIES
Human aquaporin 7 (AQP7) from ORIGENE TECHNOLOGIESTP31236320 ugORIGENE TECHNOLOGIES
Human aquaporin 9 (AQP9) from ORIGENE TECHNOLOGIESTP32456720 ugORIGENE TECHNOLOGIES
Human aprataxin and PNKP like factor (APLF), full length from ORIGENE TECHNOLOGIESTP71032220 ugORIGENE TECHNOLOGIES
Human aquaporin 1 (Colton blood group) (AQP1), transcript variant 4. from ORIGENE TECHNOLOGIESTP32959920 ugORIGENE TECHNOLOGIES
Human aquaporin 3 (Gill blood group) (AQP3) from ORIGENE TECHNOLOGIESTP30185620 ugORIGENE TECHNOLOGIES
Human aquarius homolog (mouse) (AQR) from ORIGENE TECHNOLOGIESTP32074220 ugORIGENE TECHNOLOGIES
Human arachidonate 5-lipoxygenase-activating protein (ALOX5AP) from ORIGENE TECHNOLOGIESTP30378520 ugORIGENE TECHNOLOGIES
Human arachidonate 12-lipoxygenase (ALOX12) from ORIGENE TECHNOLOGIESTP31021120 ugORIGENE TECHNOLOGIES
Human arachidonate 15-lipoxygenase (ALOX15) from ORIGENE TECHNOLOGIESTP30662120 ugORIGENE TECHNOLOGIES
Human arachidonate 5-lipoxygenase (ALOX5) from ORIGENE TECHNOLOGIESTP31725920 ugORIGENE TECHNOLOGIES
Human aquaporin 1 (Colton blood group) (AQP1) from ORIGENE TECHNOLOGIESTP30530420 ugORIGENE TECHNOLOGIES
Human Breast, left; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7154305x5umORIGENE TECHNOLOGIES
Human Breast, left; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS5198525x5umORIGENE TECHNOLOGIES
Human Breast, left; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS5515285x5umORIGENE TECHNOLOGIES
Human Breast, left; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS5515275x5umORIGENE TECHNOLOGIES
Human Breast, left; Lobular hyperplasia of breast, atypical from ORIGENE TECHNOLOGIESCS7156975x5umORIGENE TECHNOLOGIES
Human Breast, left medial; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS5515245x5umORIGENE TECHNOLOGIES
Human Breast, left; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS8117035x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS7101625x5umORIGENE TECHNOLOGIES
Human Breast, left medial; Adenocarcinoma of breast, ductal, lobular features from ORIGENE TECHNOLOGIESCS5516225x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS7113475x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS7112685x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS7147225x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS7140635x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS7112675x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS7150925x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS8144805x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS7156985x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS5486615x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS5486655x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS7160325x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS5496675x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS5496625x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS5496685x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS5538585x5umORIGENE TECHNOLOGIES
Human Breast, left, normal from ORIGENE TECHNOLOGIESCS5526645x5umORIGENE TECHNOLOGIES
Human serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 (SERPINE2), transcript variant 1 from ORIGENE TECHNOLOGIESTP30490420 ugORIGENE TECHNOLOGIES
Human serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 (SERPINE1), transcript variant 1 from ORIGENE TECHNOLOGIESTP72068310 ugORIGENE TECHNOLOGIES
Human serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 (SERPINE1), transcript variant 1. from ORIGENE TECHNOLOGIESTP72335010 ugORIGENE TECHNOLOGIES
Human serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 (SERPINF1) from ORIGENE TECHNOLOGIESTP30418620 ugORIGENE TECHNOLOGIES
Human serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 (SERPINF1) from ORIGENE TECHNOLOGIESTP72044310 ugORIGENE TECHNOLOGIES
Human serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 (SERPINF2) from ORIGENE TECHNOLOGIESTP30643520 ugORIGENE TECHNOLOGIES
Human serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 (SERPINF1). from ORIGENE TECHNOLOGIESTP72335920 ugORIGENE TECHNOLOGIES
Human serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 (SERPINF2), transcript variant 3 from ORIGENE TECHNOLOGIESTP32834220 ugORIGENE TECHNOLOGIES
Human serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 (SERPING1), transcript variant 2 from ORIGENE TECHNOLOGIESTP32311220 ugORIGENE TECHNOLOGIES
Human serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 (SERPING1), transcript variant 1 from ORIGENE TECHNOLOGIESTP72044410 ugORIGENE TECHNOLOGIES
Human serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 (SERPING1), transcript variant 1 from ORIGENE TECHNOLOGIESTP30376720 ugORIGENE TECHNOLOGIES
Human serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 (SERPING1), transcript variant 1. from ORIGENE TECHNOLOGIESTP72304950 ugORIGENE TECHNOLOGIES
Human serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) (SERPINH1) from ORIGENE TECHNOLOGIESTP30984720 ugORIGENE TECHNOLOGIES
 |< < 1180 1181 1182 1183 1184 1185 1186 1187 1188 > >| 第 1188/6274 页